New antifungal stick could simplify Athlete's foot treatment
NCT ID NCT07245667
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests three different stick formulations of the antifungal drug tolnaftate (1%) for treating athlete's foot (tinea pedis). About 150 people aged 16 and older with a confirmed diagnosis will apply the stick twice daily for 4 weeks. The main goal is to see if the infection is completely cleared at week 4.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tolnaftate 1% (antifungal) in a stick formulation
What this could lead to
If successful, this could provide a more convenient and effective topical treatment for athlete's foot.
What could go wrong
This is an early Phase 2 trial with only 150 participants. The new stick formulations may not work better than existing treatments, and results may not apply to all types of athlete's foot.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TINEA PEDIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kuchnir Dermatology and Dermatological Surgery
RECRUITINGFramingham, Massachusetts, 01701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kuchnir Dermatology and Dermatological Surgery
RECRUITINGMilford, Massachusetts, 01757, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••